Amendment: SEC Form SCHEDULE 13D/A filed by Zedge Inc.
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)
|
Zedge, Inc. (Name of Issuer) |
Class B Common Stock, par value $0.01 per share (Title of Class of Securities) |
98923T104 (CUSIP Number) |
Michael Jonas c/o Zedge, Inc., 1178 Broadway, 3rd Floor #1450 New York, NY, 10001 (330) 577-3424 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
10/28/2025 (Date of Event Which Requires Filing of This Statement) |

SCHEDULE 13D
|
| CUSIP No. | 98923T104 |
| 1 |
Name of reporting person
Michael Jonas | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
2,042,254.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
15.7 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Class B Common Stock, par value $0.01 per share |
| (b) | Name of Issuer:
Zedge, Inc. |
| (c) | Address of Issuer's Principal Executive Offices:
1178 Broadway, 3rd Floor #1450, New York,
NEW YORK
, 10001. |
| Item 2. | Identity and Background |
| (a) | Michael Jonas. |
| (b) | c/o Zedge, Inc., 1178 Broadway, 3rd Floor #1450, New York, NY 10001 |
| (c) | Mr. Jonas is Executive Chairman and Chairman of the Board of Directors of the Company. |
| (d) | During the last five years, Mr. Jonas has not been convicted in a criminal proceeding. During the last five years, Mr. Jonas was not a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and is not subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, nor a finding of any violation with respect to such laws. Mr. Jonas is a United States citizen. |
| Item 3. | Source and Amount of Funds or Other Consideration |
The matters set forth in Item 4 of this Amendment are incorporated in this Item 3 by reference as if fully set forth herein. | |
| Item 4. | Purpose of Transaction |
On September 7, 2024, Mr. Jonas received 3,654 shares of Class B Common Stock upon the vesting of previously granted deferred stock units.
On September 8, 2025, Mr. Jonas received 4,233 shares of Class B Common Stock upon the vesting of previously granted deferred stock units.
On October 28, 2025, the Company reported in its Annual Report on Form 10-K that, as of October 24, 2025, the Company had 524,775 shares of Class A common stock and 12,479,136 shares of Class B Common Stock outstanding. This reflected a decrease in the total shares of Class B Common Stock outstanding, primarily attributable to purchases of outstanding Class B Common Stock by the Company under a $5 million share repurchase program. As a result of such decrease in the total outstanding shares of Class B Common Stock, Mr. Jonas' percentage of beneficial ownership of the total outstanding shares of Class B Common Stock has increased. | |
| Item 5. | Interest in Securities of the Issuer |
| (a) | As of the date hereof, Mr. Jonas beneficially owns 2,042,254 shares, which includes (i) 524,775 shares of Class A Common Stock (by virtue of the fact that they are convertible into shares of the Company's Class B Common Stock on a one-for-one basis), and (ii) 1,517,479 shares of Class B Common Stock, including 77,472 unvested restricted shares (of which 38,736 shares are scheduled to vest on each of February 9, 2026 and February 8, 2027). |
| (b) | These 2,042,254 shares represent approximately 15.7% of the issued and outstanding shares and 61.2% of the combined voting power of the Company's outstanding capital stock based on 524,775 shares of Class A Common Stock and 12,479,136 shares of Class B Common Stock issued and outstanding as of October 24, 2025, as reported in the Company's most recently filed Annual Report on Form 10-K.
As used herein, the term "beneficially owns" shall be construed as defined by Rule 13d-3 promulgated under the Securities Exchange Act of 1934. |
| (c) | Except as described herein, no transactions in the Class B Common Stock were effectuated by the Reporting Person during the 60 days prior to the date of this Amendment. |
| (d) | Not applicable. |
| (e) | Not applicable. |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
Not applicable. | |
| Item 7. | Material to be Filed as Exhibits. |
Not applicable. |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
(b)